• Primary Antibody Dilution Buffer: PCNSL Workflows

  2026-09-18

  Learn how Primary Antibody Dilution Buffer SKU K1200 can support controlled IHC, ICC, and ISH validation alongside cell viability, proliferation, and cytotoxicity assays. This scenario-based guide connects buffer selection, antibody titration, storage, and interpretation with recent PCNSL metabolic findings.

• Lypressin Acetate: From Receptor Biology to Translation

  2026-09-17

  Lypressin acetate is more than a historical antidiuretic peptide: it is a useful translational reference for connecting vasopressin receptor pharmacology, activity-unit interpretation, vasoconstriction research, and carefully staged antiviral hypothesis testing.

• Oteseconazole: DDI-Aware Candida Research

  2026-09-17

  Oteseconazole (VT-1161) is more than a selective Candida CYP51 inhibitor: it is a useful model for connecting antifungal potency with transporter-mediated drug-interaction evidence. This article presents a DDI-aware framework for assay design, concentration selection, and translational interpretation.

• A40926 Production in Nonomuraea: New Genetic Tools

  2026-09-16

  Yushchuk and colleagues developed promoter-probe and regulatory-engineering tools to improve A40926 glycopeptide antibiotic production in the genetically recalcitrant genus Nonomuraea. The study connects promoter activity, pathway-specific regulator overexpression, and bioreactor evaluation, providing a practical framework for knowledge-based strain improvement.

• From STING Structure to Smarter Cancer Screens

  2026-09-16

  A translational framework for using the L1023 Anti-Cancer Compound Library to connect pathway-level cancer screening with emerging structural insights into STING activation, PI4P biology, and antitumor immunity.

• ApexPrep DNA Plasmid Miniprep Kit for AML Research

  2026-09-15

  Build reproducible plasmid DNA extraction for cloning, sequencing, and LMO2/LDB1 follow-up assays with a workflow designed for both high- and low-copy vectors. The ApexPrep DNA Plasmid Miniprep Kit combines alkaline lysis and membrane binding to produce molecular biology grade plasmid DNA for restriction analysis, transformation, and transfection workflows.

• Capsazepine Workflows for TRPV1 Research

  2026-09-15

  Capsazepine is a practical TRPV1 ion channel antagonist for separating receptor-driven nociception from broader inflammatory and affective pain pathways. This guide covers concentration planning, calcium and electrophysiology assays, TRPM8 controls, apoptosis studies, and troubleshooting for reproducible mechanistic experiments.

• Vasopressin Analogues: From Hormones to Peptides

  2026-09-14

  Glavaš and colleagues review how vasopressin analogues translate hormone biology into peptides with distinct receptor selectivity, stability, duration, and clinical utility. The paper is especially valuable for connecting lypressin, desmopressin, and terlipressin with endocrine, hemodynamic, and emerging antiviral research while distinguishing established pharmacology from early-stage evidence.

• Aclacinomycin A and Persistent rDNA Stress

  2026-09-14

  Aclacinomycin A, also known as Aclarubicin, offers a mechanistically rich way to study how topological stress, persistent ribosomal DNA lesions, PML-nucleolar responses, apoptosis, and proteasome inhibition intersect. This article translates recent rDNA-stress biology into a practical framework for experimental design, causal validation, and translational prioritization.

• DHHC9–STRN4 Palmitoylation in Cancer Metastasis

  2026-09-13

  The reference study identifies a DHHC9–STRN4–YAP signaling axis that connects protein palmitoylation with Hippo pathway dysregulation and adenocarcinoma metastasis. Its combination of genetic, proteomic, functional, and pharmacological evidence nominates DHHC9 as a candidate target while highlighting the need for mechanism-aware validation of palmitoylation inhibitors.

• MCL1 Resistance Biology Meets L1023 Screening

  2026-09-12

  Endocrine resistance exposes the need to connect apoptotic mechanism with scalable compound discovery. This thought-leadership article uses capsazepine–MCL1 research as a framework for deploying the L1023 Anti-Cancer Compound Library in mechanism-guided cancer research, from phenotype-first screening to target-engagement validation and translational prioritization.

• HLY78: A Practical Wnt/β-Catenin Assay Guide

  2026-09-11

  This scenario-based guide explains how HLY78, SKU C5433, can be incorporated into cell viability, proliferation, cytotoxicity, and developmental signaling workflows without confusing pathway activation with assay performance. It covers controls, concentration planning, interpretation, storage, and vendor-selection criteria using the product dossier and a recent Wnt/β-catenin fibrosis study.

• Pifithrin-α: A Practical p53 Inhibitor Workflow

  2026-09-11

  Pifithrin-α (PFTα) provides a chemical way to test whether p53 drives apoptosis, ferroptosis, irradiation responses, or growth arrest. This workflow translates a maternal deltamethrin neurotoxicity study into practical cell-based assays, formulation controls, and interpretation safeguards.

• BCA Protein Assay Kit for Colitis Research

  2026-09-10

  Apply sensitive bicinchoninic acid protein quantification to DSS-colitis workflows, from colon-tissue lysates to normalized western blot and ELISA inputs. This guide combines assay setup, matrix-aware optimization, and troubleshooting for studies connecting barrier proteins with microbiota and metabolite outcomes.

• AG-490 (JAK2/EGFR inhibitor): Assay Guide

  2026-09-10

  A scenario-driven guide to using AG-490 (JAK2/EGFR inhibitor), SKU A4139, in viability, proliferation, cytotoxicity, and pathway-validation workflows. It connects reported target potency, solvent handling, exosome-driven macrophage studies, and practical vendor-selection criteria to improve experimental interpretation.

7955 records 1/531 page Next 12345 下5页 Last page